Sign in
CompletedNo phase

Transcutaneous Pulsed Radiofrequency Application Plus Genicular Nerve Block Versus Intraarticular Hyaluronic Acid Injection for Management of Chronic Pain in Knee Osteoarthritis.

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
80 people enrolled
Started
1 Aug 2023
Ended
1 Jul 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Hyaluronic acid
  • Transcutaneous pulsed radiofrequency
Record updated
29 November 2024

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Aged above 40 years
  • Both sexes
  • American Society of Anesthesiologists (ASA)physical status I and II
  • Patients radiologically proven symptomatic knee joint osteoarthritis not responding to medical treatment
  • Patients with knee pain of moderate or greater intensity on most or all days for ≥ 3 months, showing significant radiological osteoarthritis (Kellgren-Lawrence grade 1 to 3); Radiological severity was assessed using the Kellgrenand Lawrence global scale as follow: Grade 0; means absence of radiological finding; grade 1: suspected narrowing of joint space; grade 2 refers to osteophytes and possible narrowing; grade 3 is defined as multiple os-teophytes, definite narrowing of joint space and grade 4 comprises large osteophytes, marked narrowing of joint space

Who cannot take part

  • Patients who show improvement on medical treatment, patients on an oral, topical, or intra-articular steroid during the 4 weeks before the study; patients with an oral, topical, or suppository non-steroidal anti-inflammatory drugs within 2 weeks before the study
  • Patients with joint replacement surgery in either knee and/or a hip
  • Patients with meniscal tear, ligament injury, bursitis, and popliteal cyst and blood investigations suggestive of any infection
  • Infection at site of injection
  • Bleeding diathesis and coagulopathy
  • Patient refusal
  • Patients having secondary knee osteoarthritis
  • Patients with severe osteoarthritis.(K/L grade >3) in a location other than the knee joint
  • Patients with rheumatoid arthritis
  • Morbid obese patients (body mass index (BMI) of >40 kg/m2)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of the present study is to compare the analgesic efficacy of combined transcutaneous pulsed radiofrequency plus genicular nerve block with bupivacaine plus corticosteroid versus intraarticular Hyaluronic acid injections, in terms of clinical and functional parameters, in patients with knee osteoarthritis.

The 2 groups in the trial

  • Hyaluronic Acid groupTreatment being tested

    Patients underwent intra-articular hyaluronic acid injection.

    Treatment: Hyaluronic acid

  • Transcutaneous pulsed radiofrequency groupTreatment being tested

    Patients underwent transcutaneous pulsed radiofrequency application plus genicular nerve block.

    Treatment: Transcutaneous pulsed radiofrequency

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Comparative Study Between Transcutaneous Pulsed Radiofrequency Application Plus Genicular Nerve Block Versus Intra-Articular Hyaluronic Acid Injection for Management of Chronic Pain in Knee Osteo-arthritis: A Prospective Randomized Controlled Study.
Record updated
29 November 2024